Podcast Episode Details
Back to Podcast Episodes
Cramer's Morning Take: Bristol Myers & Eli Lilly 11/25/24
Jim and Jeff discuss why they’re buying this biopharmaceutical stock. They also talk about adding to this pharmaceutical stock. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake
CNBC Investing Club Disclaimer
Published on 1 year, 1 month ago